NCT05846516 2026-03-17A Study to Test KISIMA-02 Vaccine-based Immunotherapy and Ezabenlimab in People With Pancreatic CancerBoehringer IngelheimPhase 1 Active not recruiting58 enrolled
NCT05209074 2025-09-05Ivosidenib + mFOLFIRINOX in Patients With Resectable Pancreatic AdenocarcinomaCase Comprehensive Cancer CenterPhase 1 Active not recruiting16 enrolled